3D Global Biotech (6808) Stock Overview

3D Global Biotech Inc. develops a 3D human organ bio-printing technology platform and composite bio-ink for printing a variety of cells to reconstruct tissues and organs. The company offers reconstruction of human tissues and organs; and manufactures customized and personalized medical devices. It provides 3D printing technology and inspection services. The company offers artificial bone grafting products, cranial and maxillofacial implants, bio-dressings, bio-inks, and 3D printing equipment, as well as orthodontic, PacDent, and ophthalmic products. It serves medical centers, research institutions, and companies and distributors to establish an interdisciplinary alliance encompassing industry, government, academia, research, and medicine. The company was founded in 2014 and is based in New Taipei City, China.